Postnatal Anti-Interferon-γ Treatment Prevents Pancreatic Inflammation in Transgenic Mice with β-Cell Expression of Interferon-γ

Lise Wogensen, Leslie Molony, Danling Gu, Troy Krahl, Simin Zhu, Nora Sarvetnick

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

β-Cell-targeted expression of interferon-γ (IFN-γ) leads to pancreatitis and immune sensitization to β-cells. This transgenic model is used to explore the possible role of locally produced IFN-γ in loss of tolerance to β-cell-specific antigens in insulin-dependent diabetes mellitus (IDDM). The aim of the present study was to test if postnatal treatment with antibodies against IFN-γ could inhibit morphological changes in the IFN-γ transgenic pancreas, even though the transgene is expressed during embryogenesis. Treatment with a monoclonal rat anti-mouse IFN-γ antibody for 6 weeks, starting from 5 to 7 days of age, completely inhibited IFN-γ-induced morphological changes in the pancreas, and only a modest inflammatory reaction emerged after prolonged treatment for 12 weeks. The lack of morphological changes may reflect the ability of nonterminally differentiated neonatal pancreatic cells to compensate for transgene-induced pathological alterations occurring in utero prior to the antibody treatment. We conclude that inflammation and altered pancreas morphology in the transgenic mice is the result of the biological actions of IFN-γ and not by disrupted islet development due to transgene overexpression in the pancreatic β-cells. Furthermore, our treatment schedule can serve as a model for future intervention studies in the transgenic mice, elaborating the role of IFN-γ in localized inflammatory reactions, IDDM in particular.

Original languageEnglish (US)
Pages (from-to)111-116
Number of pages6
JournalJournal of Interferon Research
Volume14
Issue number3
DOIs
StatePublished - Jun 1994

Fingerprint

Interferons
Transgenic Mice
Inflammation
Transgenes
Pancreas
Type 1 Diabetes Mellitus
Antibodies
Pancreatitis
Embryonic Development
Appointments and Schedules
Antigens

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Postnatal Anti-Interferon-γ Treatment Prevents Pancreatic Inflammation in Transgenic Mice with β-Cell Expression of Interferon-γ. / Wogensen, Lise; Molony, Leslie; Gu, Danling; Krahl, Troy; Zhu, Simin; Sarvetnick, Nora.

In: Journal of Interferon Research, Vol. 14, No. 3, 06.1994, p. 111-116.

Research output: Contribution to journalArticle

@article{d1035de3e4a743dc8990bdfe32726672,
title = "Postnatal Anti-Interferon-γ Treatment Prevents Pancreatic Inflammation in Transgenic Mice with β-Cell Expression of Interferon-γ",
abstract = "β-Cell-targeted expression of interferon-γ (IFN-γ) leads to pancreatitis and immune sensitization to β-cells. This transgenic model is used to explore the possible role of locally produced IFN-γ in loss of tolerance to β-cell-specific antigens in insulin-dependent diabetes mellitus (IDDM). The aim of the present study was to test if postnatal treatment with antibodies against IFN-γ could inhibit morphological changes in the IFN-γ transgenic pancreas, even though the transgene is expressed during embryogenesis. Treatment with a monoclonal rat anti-mouse IFN-γ antibody for 6 weeks, starting from 5 to 7 days of age, completely inhibited IFN-γ-induced morphological changes in the pancreas, and only a modest inflammatory reaction emerged after prolonged treatment for 12 weeks. The lack of morphological changes may reflect the ability of nonterminally differentiated neonatal pancreatic cells to compensate for transgene-induced pathological alterations occurring in utero prior to the antibody treatment. We conclude that inflammation and altered pancreas morphology in the transgenic mice is the result of the biological actions of IFN-γ and not by disrupted islet development due to transgene overexpression in the pancreatic β-cells. Furthermore, our treatment schedule can serve as a model for future intervention studies in the transgenic mice, elaborating the role of IFN-γ in localized inflammatory reactions, IDDM in particular.",
author = "Lise Wogensen and Leslie Molony and Danling Gu and Troy Krahl and Simin Zhu and Nora Sarvetnick",
year = "1994",
month = "6",
doi = "10.1089/jir.1994.14.111",
language = "English (US)",
volume = "14",
pages = "111--116",
journal = "Journal of Interferon Research",
issn = "0197-8357",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Postnatal Anti-Interferon-γ Treatment Prevents Pancreatic Inflammation in Transgenic Mice with β-Cell Expression of Interferon-γ

AU - Wogensen, Lise

AU - Molony, Leslie

AU - Gu, Danling

AU - Krahl, Troy

AU - Zhu, Simin

AU - Sarvetnick, Nora

PY - 1994/6

Y1 - 1994/6

N2 - β-Cell-targeted expression of interferon-γ (IFN-γ) leads to pancreatitis and immune sensitization to β-cells. This transgenic model is used to explore the possible role of locally produced IFN-γ in loss of tolerance to β-cell-specific antigens in insulin-dependent diabetes mellitus (IDDM). The aim of the present study was to test if postnatal treatment with antibodies against IFN-γ could inhibit morphological changes in the IFN-γ transgenic pancreas, even though the transgene is expressed during embryogenesis. Treatment with a monoclonal rat anti-mouse IFN-γ antibody for 6 weeks, starting from 5 to 7 days of age, completely inhibited IFN-γ-induced morphological changes in the pancreas, and only a modest inflammatory reaction emerged after prolonged treatment for 12 weeks. The lack of morphological changes may reflect the ability of nonterminally differentiated neonatal pancreatic cells to compensate for transgene-induced pathological alterations occurring in utero prior to the antibody treatment. We conclude that inflammation and altered pancreas morphology in the transgenic mice is the result of the biological actions of IFN-γ and not by disrupted islet development due to transgene overexpression in the pancreatic β-cells. Furthermore, our treatment schedule can serve as a model for future intervention studies in the transgenic mice, elaborating the role of IFN-γ in localized inflammatory reactions, IDDM in particular.

AB - β-Cell-targeted expression of interferon-γ (IFN-γ) leads to pancreatitis and immune sensitization to β-cells. This transgenic model is used to explore the possible role of locally produced IFN-γ in loss of tolerance to β-cell-specific antigens in insulin-dependent diabetes mellitus (IDDM). The aim of the present study was to test if postnatal treatment with antibodies against IFN-γ could inhibit morphological changes in the IFN-γ transgenic pancreas, even though the transgene is expressed during embryogenesis. Treatment with a monoclonal rat anti-mouse IFN-γ antibody for 6 weeks, starting from 5 to 7 days of age, completely inhibited IFN-γ-induced morphological changes in the pancreas, and only a modest inflammatory reaction emerged after prolonged treatment for 12 weeks. The lack of morphological changes may reflect the ability of nonterminally differentiated neonatal pancreatic cells to compensate for transgene-induced pathological alterations occurring in utero prior to the antibody treatment. We conclude that inflammation and altered pancreas morphology in the transgenic mice is the result of the biological actions of IFN-γ and not by disrupted islet development due to transgene overexpression in the pancreatic β-cells. Furthermore, our treatment schedule can serve as a model for future intervention studies in the transgenic mice, elaborating the role of IFN-γ in localized inflammatory reactions, IDDM in particular.

UR - http://www.scopus.com/inward/record.url?scp=0027964490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027964490&partnerID=8YFLogxK

U2 - 10.1089/jir.1994.14.111

DO - 10.1089/jir.1994.14.111

M3 - Article

C2 - 7930757

AN - SCOPUS:0027964490

VL - 14

SP - 111

EP - 116

JO - Journal of Interferon Research

JF - Journal of Interferon Research

SN - 0197-8357

IS - 3

ER -